Tech Company Financing Transactions
Limerick BioPharma Funding Round
On 7/26/2011, Limerick BioPharma landed $3.1 million in funding from private investors.
Transaction Overview
Company Name
Announced On
7/26/2011
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$3,050,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing-amended.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
601 Gateway Blvd. 1050
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Limerick BioPharma is dedicated to developing compounds that, when used adjunctively with both marketed and investigational drugs, significantly improve the quality of patients' lives. Our compounds minimize toxic side effects at non-targeted vulnerable organs and tissue while maintaining or enhancing a drug's desired effects.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Wendye Robbins
Chief Financial Officer
Asha Rajagopal
Chief Scientific Officer
Ving Lee
VP - R & D
Michael Chang
Browse more venture capital transactions:
Prev: 7/26/2011: Are You a Human venture capital transaction
Next: 7/26/2011: Wildcat Discovery Technologies venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs